TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 705.0M
Gross Profit 341.0M 48.37%
Operating Income 109.0M 15.46%
Net Income 71.0M 10.07%
EPS (Diluted) $0.33

Balance Sheet Metrics

Total Assets 2.9B
Total Liabilities 1.9B
Shareholders Equity 984.0M
Debt to Equity 1.92

Cash Flow Metrics

Operating Cash Flow 240.0M
Free Cash Flow 103.0M

Revenue & Profitability Trend

Ul Solutions Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i2.9B2.7B2.5B2.5B-
Cost of Goods Sold i1.5B1.4B1.3B1.3B-
Gross Profit i1.4B1.3B1.2B1.2B-
Gross Margin % i48.5%47.8%47.9%46.8%0.0%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i931.0M875.0M795.0M892.0M668.0M
Other Operating Expenses i-----
Total Operating Expenses i931.0M875.0M795.0M892.0M668.0M
Operating Income i462.0M405.0M412.0M287.0M363.0M
Operating Margin % i16.1%15.1%16.3%11.4%0.0%
Non-Operating Items
Interest Income i4.0M12.0M1.0M7.0M-
Interest Expense i55.0M35.0M17.0M1.0M-
Other Non-Operating Income4.0M-36.0M-13.0M-19.0M-29.0M
Pre-tax Income i415.0M346.0M383.0M274.0M-
Income Tax i70.0M70.0M74.0M36.0M-
Effective Tax Rate % i16.9%20.2%19.3%13.1%0.0%
Net Income i345.0M276.0M309.0M238.0M-
Net Margin % i12.0%10.3%12.3%9.5%0.0%
Key Metrics
EBITDA i629.0M565.0M524.0M419.0M478.0M
EPS (Basic) i$1.63$1.30$1.47$1.12$1.16
EPS (Diluted) i$1.62$1.30$1.47$1.12$1.16
Basic Shares Outstanding i200000000200000000200000000200000000200000000
Diluted Shares Outstanding i200000000200000000200000000200000000200000000

Income Statement Trend

Ul Solutions Balance Sheet From 2021 to 2024

Metric2024202320222021
Assets
Current Assets
Cash & Equivalents i298.0M315.0M322.0M1.3B
Short-term Investments i-051.0M47.0M
Accounts Receivable i380.0M362.0M376.0M368.0M
Inventory i----
Other Current Assets4.0M13.0M5.0M6.0M
Total Current Assets i921.0M953.0M998.0M2.0B
Non-Current Assets
Property, Plant & Equipment i186.0M151.0M156.0M151.0M
Goodwill i1.5B1.5B1.5B1.4B
Intangible Assets i185.0M211.0M200.0M196.0M
Long-term Investments----
Other Non-Current Assets244.0M243.0M176.0M200.0M
Total Non-Current Assets i1.9B1.8B1.7B1.7B
Total Assets i2.8B2.7B2.7B3.7B
Liabilities
Current Liabilities
Accounts Payable i182.0M169.0M153.0M179.0M
Short-term Debt i88.0M39.0M42.0M36.0M
Current Portion of Long-term Debt----
Other Current Liabilities54.0M58.0M46.0M59.0M
Total Current Liabilities i740.0M709.0M694.0M792.0M
Non-Current Liabilities
Long-term Debt i847.0M1.0B618.0M118.0M
Deferred Tax Liabilities i---15.0M
Other Non-Current Liabilities86.0M93.0M85.0M84.0M
Total Non-Current Liabilities i1.1B1.3B949.0M538.0M
Total Liabilities i1.9B2.1B1.6B1.3B
Equity
Common Stock i0000
Retained Earnings i250.0M24.0M211.0M1.5B
Treasury Stock i----
Other Equity----
Total Shareholders Equity i931.0M678.0M1.1B2.3B
Key Metrics
Total Debt i935.0M1.1B660.0M154.0M
Working Capital i181.0M244.0M304.0M1.2B

Balance Sheet Composition

Ul Solutions Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i345.0M276.0M309.0M238.0M-
Depreciation & Amortization i172.0M154.0M135.0M142.0M-
Stock-Based Compensation i23.0M00--
Working Capital Changes i-24.0M10.0M-23.0M18.0M0
Operating Cash Flow i524.0M462.0M439.0M321.0M-
Investing Activities
Capital Expenditures i-----
Acquisitions i3.0M-14.0M-66.0M-47.0M-
Investment Purchases i0-95.0M-162.0M-172.0M-
Investment Sales i0144.0M155.0M495.0M-
Investing Cash Flow i3.0M40.0M-74.0M285.0M-
Financing Activities
Share Repurchases i-----
Dividends Paid i-100.0M-680.0M-1.6B-200.0M-
Debt Issuance i181.0M440.0M700.0M00
Debt Repayment i-346.0M-30.0M-200.0M00
Financing Cash Flow i-284.0M-294.0M-1.1B-228.0M0
Free Cash Flow i287.0M252.0M208.0M314.0M-
Net Change in Cash i243.0M208.0M-751.0M378.0M0

Cash Flow Trend

Ul Solutions Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 41.25
Forward P/E 39.54
Price to Book 12.28
Price to Sales 4.55
PEG Ratio -3.51

Profitability Ratios

Profit Margin 11.08%
Operating Margin 17.78%
Return on Equity 36.55%
Return on Assets 10.77%

Financial Health

Current Ratio 1.32
Debt to Equity 72.33

Per Share Data

EPS (TTM) $1.62
Book Value per Share $5.44
Revenue per Share $14.72

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
uls13.4B41.2512.2836.55%11.08%72.33
Cintas 86.4B48.8118.4340.27%17.53%56.67
Copart 45.5B31.185.1818.44%32.21%1.15
Global Payments 21.0B14.760.936.59%14.20%71.17
Rb Global 19.9B52.983.777.39%9.68%76.45
Rentokil Initial plc 12.5B38.3311.565.13%4.46%115.51

Financial data is updated regularly. All figures are in the company's reporting currency.